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In considering the future role of the volatile anesthetic
desflurane (Suprane®) in modern anesthesia practice, it
is important to first consider the factors that contribute
to a successful anesthetic in this increasingly day surgery
orientation. An optimal anesthetic for the new millen-
nium would include the following characteristics.
1. It should have a rapid and smooth onset of action.
Efficiency is a particularly important factor in the
ambulatory setting [1]
2. There should be a rapid recovery of cognitive
functioning without clinically-significant discomfort.
Postoperative pain is a major limiting factor in
determining when a patient can be discharged home
after surgery.
3. The absence of adverse effects such as nausea and
vomiting is extremely important as emetic symptoms
affect not only recovery times but also the incidence
of unanticipated hospital admissions after day-case
surgery, and patient satisfaction with their overall
anesthetic experience.
The low solubility of desflurane contributes to rapid
emergence after anesthesia. Compared with sevoflurane,
recovery times to eye opening, response to verbal com-
mands, and orientation to person, place, and time have
been found to be significantly shorter with desflurane
[2-4]. When compared with the rapid, short-acting
intravenous anesthetic propofol for induction and main-
tenance of anesthesia, desflurane displayed more favor-
able early recovery characteristics and facilitated the
fast-tracking process [4,5]. Although patients receiving
desflurane are less sedated in the early postoperative
period than those receiving propofol, times to ambula-
tion and discharge were similar.
Given its favorable early recovery profile, desflurane
would appear to be a useful alternative to isoflurane,
sevoflurane and propofol for maintenance of anesthesia
i nab u s yp r a c t i c ee n v i r o n m e n tw h e r ee a r l yd i s c h a r g ei s
one of the major goals (e.g., cardiovascular, neurosur-
gery, day-case surgery).
In conclusion, desflurane is the maintenance
anesthetic agent of choice in a fast-tracking practice
environment.
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